VivoSeq
Other

Propofol

2

Pipeline Programs

7

Active Trials

6

Companies Involved

Propofol is an early-stage landscape with 2 programs across 6 companies. The most active players are McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc., Fresenius Kabi Oncology Ltd., Haisco Pharmaceutical Group Co., Ltd.. 2 therapies are approved.

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

11/100

Mech. Concentration

50/100

Completion Rate

98/100

Attrition Rate

2/100

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs

Trial Status

63

clinical trials

Completed51 · 81%
Recruiting6 · 10%
Unknown status4 · 6%
Active, not recruiting1 · 2%
Withdrawn1 · 2%

Trial Activity

63 trials

Etomidate Versus Propofol in CABG Surgery
Recruiting·HHartford Hospital·Phase 4·NCT06068764·300 enrolled
Effect of Mannitol on Propofol Level
Recruiting··Phase 4·NCT06884657·40 enrolled
Neural and Antidepressant Effects of Propofol
Active, not recruiting·UUniversity of Utah·Phase 2/3·NCT03684447·48 enrolled
Propofol Pharmacokinetics and Pharmacodynamics Modelling
Completed··N/A·NCT02713698·60 enrolled
Preventing Propofol-associated Injection Pain
Completed··Phase 4·NCT00864682·156 enrolled
Effect of Desflurane v/s Propofol on the Optic Nerve Sheath Diameter
Completed··Phase 4·NCT07359508·146 enrolled
Use of a Modified Propofol Emulsion in Adults
Completed·BB. Braun Melsungen AG·Phase 3·NCT00690495·100 enrolled
Page 1 of 5

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)